Drug recall D-1334-2022
Product
Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56
Reason for recall
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
Lots and codes
Lot: FE22001A, Exp 01/2024
Recall details
- Recalling firm
- Teva Pharmaceuticals USA Inc, Parsippany, NJ
- Quantity
- 4162 cartons
- Distribution
- Distributed in Ohio
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 22, 2022
- Terminated
- April 12, 2023
Related products
- Azacitidine – drug information
- NDC 68001-313 Azacitidine · Azacitidine 100 mg/1 · BluePoint Laboratories